Health care companies by P/B ratio
Share price divided by book value per share: what the market pays for each dollar of shareholders' equity on the balance sheet.
CVS Health has the lowest figure of the 128 health care companies ranked by P/B ratio, at 1.3, followed by Bio-Rad Laboratories (1.3) and MiniMed Group (1.3). Figures as of 19 Nov 2026, 06:49 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 128
- Lowest
- CVS Health1.3
- Median
- 5.3
- Combined market value
- CZK 202.37T
- Countries
- 14
- Not ranked
- 42no P/B ratio on file
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | P/B ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | CVS HealthCVS · Health Care | 1.3 | CZK 2.32T | CZK 1,810.09 | 5.20% down | 12% up | ||
| 2 | Bio-Rad LaboratoriesBIO · Health Care | 1.3 | CZK 221.5B | CZK 8,236.54 | 3.34% up | 18% up | ||
| 3 | MiniMed GroupMMED · Health Care | 1.3 | CZK 106.4B | CZK 378.04 | 4.44% down | 4% down | ||
| 4 | Cooper CompaniesCOO · Health Care | 1.4 | CZK 257B | CZK 1,351.73 | 0.05% up | 16% down | ||
| 5 | Universal Health ServicesUHS · Health Care | 1.4 | CZK 238.7B | CZK 4,140.19 | 3.08% down | 16% down | ||
| 6 | CenteneCNC · Health Care | 1.5 | CZK 743B | CZK 1,500.81 | 7.03% down | 102% up | ||
| 7 | Zimmer Biomet HoldingsZBH · Health Care | 1.5 | CZK 435.1B | CZK 2,298.94 | 1.20% up | 14% up | ||
| 8 | ViatrisVTRS · Health Care | 1.7 | CZK 517.3B | CZK 451.24 | 0.83% down | 96% up | ||
| 9 | Cigna GroupCI · Health Care | 1.7 | CZK 1.67T | CZK 6,349.68 | 2.96% down | 8% up | ||
| 10 | AvantorAVTR · Health Care | 1.8 | CZK 231.7B | CZK 341.99 | 1.25% up | 38% up | ||
| 11 | PfizerPFE · Health Care | 1.8 | CZK 3.56T | CZK 624.35 | 1.44% down | 14% up | ||
| 12 | GRAILGRAL · Health Care | 1.9 | CZK 102.1B | CZK 2,271.80 | 3.57% down | 20% up | ||
| 13 | BioMarin PharmaceuticalBMRN · Health Care | 1.9 | CZK 264.8B | CZK 1,366.86 | 4.99% up | 11% up | ||
| 14 | TeleflexTFX · Health Care | 1.9 | CZK 146.4B | CZK 3,690.28 | 3.95% up | 51% up | ||
| 15 | Elevance HealthELV · Health Care | 1.9 | CZK 1.93T | CZK 8,918.97 | 7.63% down | 37% up | ||
| 16 | Globus MedicalGMED · Health Care | 2.0 | CZK 207.9B | CZK 1,569.34 | 0.77% up | 16% down | ||
| 17 | BiogenBIIB · Health Care | 2.0 | CZK 826.9B | CZK 5,594.05 | 0.25% up | 49% up | ||
| 18 | Elanco Animal HealthELAN · Health Care | 2.0 | CZK 296.9B | CZK 594.09 | 3.29% up | 20% up | ||
| 19 | Baxter InternationalBAX · Health Care | 2.1 | CZK 301.1B | CZK 582.08 | 1.55% up | 46% up | ||
| 20 | RevvityRVTY · Health Care | 2.3 | CZK 378.6B | CZK 3,391.67 | 3.14% up | 60% up | ||
| 21 | Becton, DickinsonBDX · Health Care | 2.4 | CZK 1.31T | CZK 4,807.93 | 0.31% up | 43% up | ||
| 22 | HumanaHUM · Health Care | 2.5 | CZK 1.03T | CZK 8,583.88 | 12.98% down | 94% up | ||
| 23 | Boston ScientificBSX · Health Care | 2.5 | CZK 1.41T | CZK 971.02 | 1.42% up | 56% down | ||
| 24 | Legend BiotechLEGN · Health Care | 2.5 | CZK 70.1B | CZK 361.57 | 0.87% up | 42% down | ||
| 25 | Molina HealthcareMOH · Health Care | 2.6 | CZK 239.9B | CZK 4,596.10 | 6.62% down | 60% up | ||
| 26 | Align TechnologyALGN · Health Care | 2.7 | CZK 257.2B | CZK 3,648.22 | 0.31% up | 22% up | ||
| 27 | Edgewise TherapeuticsEWTX · Health Care | 2.8 | CZK 100.8B | CZK 920.51 | 1.59% down | 88% up | ||
| 28 | Regeneron PharmaceuticalsREGN · Health Care | 2.8 | CZK 2.18T | CZK 21,038.70 | 1.28% down | 36% up | ||
| 29 | MedlineMDLN · Health Care | 2.9 | CZK 1.15T | CZK 871.34 | 3.93% up | 8% down | ||
| 30 | Merit Medical SystemsMMSI · Health Care | 3.0 | CZK 114.6B | CZK 1,912.00 | 1.70% up | 1% up | ||
| 31 | WatersWAT · Health Care | 3.0 | CZK 2.04T | CZK 10,371.05 | 3.63% up | 20% up | ||
| 32 | Henry ScheinHSIC · Health Care | 3.0 | CZK 210.8B | CZK 1,906.66 | 3.32% up | 17% up | ||
| 33 | DanaherDHR · Health Care | 3.0 | CZK 3.58T | CZK 5,086.07 | 1.24% up | 2% up | ||
| 34 | SolventumSOLV · Health Care | 3.1 | CZK 327B | CZK 1,924.24 | 0.49% up | 11% up | ||
| 35 | UnitedHealth GroupUNH · Health Care | 3.2 | CZK 6.98T | CZK 7,785.74 | 10.21% down | 26% up | ||
| 36 | GE HealthCare TechnologiesGEHC · Health Care | 3.3 | CZK 841.7B | CZK 1,861.49 | 2.22% up | 13% up | ||
| 37 | Labcorp HoldingsLH · Health Care | 3.4 | CZK 669.9B | CZK 8,250.11 | 0.69% up | 41% up | ||
| 38 | LifeStance Health GroupLFST · Health Care | 3.5 | CZK 116.5B | CZK 306.39 | 2.82% down | 129% up | ||
| 39 | VaxcytePCVX · Health Care | 3.5 | CZK 206.1B | CZK 1,302.11 | 1.48% down | 22% up | ||
| 40 | Abbott LaboratoriesABT · Health Care | 3.5 | CZK 4.03T | CZK 2,324.75 | 0.22% down | 17% down | ||
| 41 | Option Care HealthOPCH · Health Care | 3.6 | CZK 105.7B | CZK 705.57 | 0.25% up | 14% up | ||
| 42 | Quest DiagnosticsDGX · Health Care | 3.7 | CZK 635.7B | CZK 5,778.28 | 1.30% up | 38% up | ||
| 43 | Dianthus TherapeuticsDNTH · Health Care | 3.8 | CZK 105.2B | CZK 1,868.61 | 3.45% down | 113% up | ||
| 44 | Oscar HealthOSCR · Health Care | 3.8 | CZK 190.6B | CZK 613.45 | 7.61% down | 112% up | ||
| 45 | United TherapeuticsUTHR · Health Care | 3.9 | CZK 547.1B | CZK 12,846.22 | 1.16% down | 23% up | ||
| 46 | Tenet HealthcareTHC · Health Care | 4.0 | CZK 480.5B | CZK 6,037.50 | 3.80% down | 45% up | ||
| 47 | HealthEquityHQY · Health Care | 4.1 | CZK 179.1B | CZK 2,165.22 | 4.45% down | 2% down | ||
| 48 | Definium TherapeuticsDFTX · Health Care | 4.1 | CZK 88.7B | CZK 647.94 | 0.88% down | 169% up | ||
| 49 | Ensign GroupENSG · Health Care | 4.1 | CZK 237.5B | CZK 4,071.43 | 1.63% down | 4% up | ||
| 50 | BrukerBRKR · Health Care | 4.2 | CZK 215B | CZK 1,407.58 | 3.10% up | 41% up | ||
| 51 | Neurocrine BiosciencesNBIX · Health Care | 4.3 | CZK 366.8B | CZK 3,623.75 | 1.84% down | 20% up | ||
| 52 | IncyteINCY · Health Care | 4.3 | CZK 534.3B | CZK 2,621.13 | 1.08% down | 18% up | ||
| 53 | Royalty PharmaRPRX · Health Care | 4.5 | CZK 878.6B | CZK 1,527.96 | 0.01% down | 78% up | ||
| 54 | RepligenRGEN · Health Care | 4.7 | CZK 245.6B | CZK 3,842.03 | 6.47% up | 5% up | ||
| 55 | Thermo Fisher ScientificTMO · Health Care | 4.7 | CZK 5.71T | CZK 15,413.95 | 0.87% up | 20% up | ||
| 56 | MSA SafetyMSA · Health Care | 4.8 | CZK 152.1B | CZK 3,948.39 | 2.67% up | 11% up | ||
| 57 | Lantheus HoldingsLNTH · Health Care | 4.9 | CZK 148.4B | CZK 2,269.57 | 0.20% up | 93% up | ||
| 58 | Charles River Laboratories InternationalCRL · Health Care | 4.9 | CZK 355.3B | CZK 7,415.05 | 0.33% up | 105% up | ||
| 59 | Encompass HealthEHC · Health Care | 4.9 | CZK 294.6B | CZK 3,002.29 | 2.14% down | 23% up | ||
| 60 | RadNetRDNT · Health Care | 5.0 | CZK 125.9B | CZK 1,598.05 | 4.14% down | 7% down | ||
| 61 | StrykerSYK · Health Care | 5.2 | CZK 2.69T | CZK 7,079.06 | 0.19% up | 13% down | ||
| 62 | Bristol-Myers SquibbBMY · Health Care | 5.2 | CZK 2.71T | CZK 1,325.25 | 2.92% down | 34% up | ||
| 63 | ErascaERAS · Health Care | 5.3 | CZK 107.5B | CZK 306.17 | 0.94% down | 403% up | ||
| 64 | Bio-TechneTECH · Health Care | 5.3 | CZK 254.3B | CZK 1,618.74 | 0.17% up | 26% up | ||
| 65 | Oruka TherapeuticsORKA · Health Care | 5.4 | CZK 144.5B | CZK 2,130.28 | 0.60% down | 241% up | ||
| 66 | Alnylam PharmaceuticalsALNY · Health Care | 5.5 | CZK 445.2B | CZK 3,324.25 | 4.54% down | 66% down | ||
| 67 | Edwards LifesciencesEW · Health Care | 5.6 | CZK 1.35T | CZK 2,341.44 | 0.19% down | 23% up | ||
| 68 | ResMedRMD · Health Care | 5.7 | CZK 759.3B | CZK 5,398.24 | 2.00% up | 3% down | ||
| 69 | PACS GroupPACS · Health Care | 6.1 | CZK 163.5B | CZK 1,030.21 | 4.63% down | 188% up | ||
| 70 | InsuletPODD · Health Care | 6.1 | CZK 216.1B | CZK 3,114.65 | 3.69% down | 58% down | ||
| 71 | Ligand PharmaceuticalsLGND · Health Care | 6.2 | CZK 132.9B | CZK 6,646.51 | 1.67% up | 43% up | ||
| 72 | HaemoneticsHAE · Health Care | 6.2 | CZK 124.5B | CZK 2,733.72 | 1.60% up | 61% up | ||
| 73 | IQVIA HoldingsIQV · Health Care | 6.4 | CZK 945.5B | CZK 5,737.12 | 0.09% up | 18% up | ||
| 74 | Kymera TherapeuticsKYMR · Health Care | 6.4 | CZK 230.1B | CZK 2,695.23 | 0.32% down | 87% up | ||
| 75 | BrightSpring Health ServicesBTSG · Health Care | 6.5 | CZK 302.6B | CZK 1,520.61 | 2.13% down | 116% up | ||
| 76 | Vertex PharmaceuticalsVRTX · Health Care | 6.5 | CZK 3.03T | CZK 11,936.39 | 0.42% up | 27% up | ||
| 77 | Krystal BiotechKRYS · Health Care | 6.5 | CZK 207.9B | CZK 7,016.54 | 5.62% up | 46% up | ||
| 78 | VeradermicsMANE · Health Care | 6.6 | CZK 117.2B | CZK 2,778.22 | 0.62% down | 233% up | ||
| 79 | Praxis Precision MedicinesPRAX · Health Care | 6.8 | CZK 189.8B | CZK 6,790.69 | 0.04% up | 61% up | ||
| 80 | Agilent TechnologiesA · Health Care | 6.8 | CZK 1.11T | CZK 3,945.72 | 2.97% up | 19% up | ||
| 81 | CG OncologyCGON · Health Care | 7.2 | CZK 159B | CZK 1,780.06 | 1.34% up | 85% up | ||
| 82 | Merck & CoMRK · Health Care | 7.6 | CZK 7.56T | CZK 3,065.70 | 3.90% down | 51% up | ||
| 83 | Protagonist TherapeuticsPTGX · Health Care | 7.6 | CZK 184.7B | CZK 2,829.40 | 2.00% up | 46% up | ||
| 84 | BillionToOneBLLN · Health Care | 7.7 | CZK 97.3B | CZK 2,036.83 | 6.11% down | 0% up | ||
| 85 | Belite BioBLTE · Health Care | 8.0 | CZK 141.2B | CZK 3,476.23 | 0.94% down | 31% up | ||
| 86 | PenumbraPEN · Health Care | 8.0 | CZK 281.2B | CZK 7,133.57 | 0.47% up | 13% up | ||
| 87 | Johnson & JohnsonJNJ · Health Care | 8.1 | CZK 14.61T | CZK 6,067.77 | 2.15% down | 38% up | ||
| 88 | ChemedCHE · Health Care | 8.2 | CZK 157.7B | CZK 12,164.90 | 0.01% down | 27% up | ||
| 89 | Caris Life SciencesCAI · Health Care | 8.7 | CZK 124.4B | CZK 433.89 | 2.21% down | 17% down | ||
| 90 | Twist BioscienceTWST · Health Care | 8.9 | CZK 176.5B | CZK 2,588.87 | 3.88% up | 340% up | ||
| 91 | Corcept TherapeuticsCORT · Health Care | 8.9 | CZK 165.1B | CZK 1,508.37 | 3.25% down | 8% down | ||
| 92 | 10x GenomicsTXG · Health Care | 9.0 | CZK 167B | CZK 1,269.85 | 1.37% up | 260% up | ||
| 93 | ExelixisEXEL · Health Care | 9.1 | CZK 370.8B | CZK 1,519.50 | 0.31% down | 63% up | ||
| 94 | Intuitive SurgicalISRG · Health Care | 9.1 | CZK 3.25T | CZK 9,366.43 | 2.23% down | 24% down | ||
| 95 | West Pharmaceutical ServicesWST · Health Care | 9.5 | CZK 626.2B | CZK 8,989.73 | 2.44% down | 61% up | ||
| 96 | Spyre TherapeuticsSYRE · Health Care | 10.1 | CZK 214.4B | CZK 2,257.56 | 8.15% up | 286% up | ||
| 97 | IlluminaILMN · Health Care | 10.1 | CZK 706.5B | CZK 4,672.87 | 3.65% up | 69% up | ||
| 98 | ImmunovantIMVT · Health Care | 10.4 | CZK 152.7B | CZK 738.06 | 0.12% down | 43% up | ||
| 99 | Concentra Group Holdings ParentCON · Health Care | 10.5 | CZK 117.4B | CZK 934.08 | 0.94% down | 120% up | ||
| 100 | ZoetisZTS · Health Care | 10.6 | CZK 773.6B | CZK 1,903.99 | 2.50% up | 29% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 22.2507 CZK). 42 companies have no P/B ratio on file and are not ranked here.
Questions and answers
Which health care companies have the lowest P/B ratio?
CVS Health (1.3), Bio-Rad Laboratories (1.3) and MiniMed Group (1.3) have the lowest P/B ratio of the 128 health care companies ranked here as of 19 Nov 2026, 06:49 UTC.
How many health care companies are in this ranking?
128 are ranked by P/B ratio. 42 more have no P/B ratio on file and are left out rather than ranked at zero.
What are these health care companies worth together?
The 128 health care companies ranked by P/B ratio have a combined market value of CZK 202.37T as of 19 Nov 2026, 06:49 UTC.
What does ranking by P/B ratio measure?
Share price divided by book value per share: what the market pays for each dollar of shareholders' equity on the balance sheet.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- Piotroski F-score: the nine tests and what they show
The Piotroski F-score is a 0–9 count of simple accounting tests a company passes: four on profitability, three on debt, liquidity and share issuance, two on operating efficiency. Joseph Piotroski's 2000 paper found that among cheap, high book-to-market stocks, high scorers went on to beat low scorers. It is a screen of financial health, not a valuation.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care companies by P/B ratio”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=pb-ratio
Underlying data: Yahoo Finance; SEC EDGAR.